title: Role of JAK2-STAT3 in TLR2-mediated tissue factor expression.
abstract: Tissue factor (TF) is a core protein with an essential function in the coagulation cascade that maintains the homeostasis of the blood vessels. TF not only participates in neointima formation, but also causes the development of atherosclerosis. This study investigated the mechanism regulating TF expression in macrophages using Pam3 CSK4 , a TLR2 ligand. Pam3 CSK4 induced TF expression in two types of macrophages (Raw264.7 and BMDM), but not in TLR2 KO mice derived BMDM. Pam3 CSK4 induced TF expression was inhibited by pretreatment with pan-JAK inhibitor or JAK2 inhibitor AG490. JAK2 knock-down by siRNA inhibited Pam3 CSK4 induced TF expression. Pam3 CSK4 stimulated STAT3 phosphorylation (S727), while STAT3 knock-down by siRNA reduced Pam3 CSK4 induced TF expression. These results suggest that Pam3 CSK4 induced TF expression is regulated by the JAK2-STAT3 signaling pathway. Pam3 CSK4 , unlike increased TF expression, significantly decreased RGS2 expression, while RGS2 overexpression decreased Pam3 CSK4 induced TF expression. Inhibition of TF by RGS2 WT did not occur in mutants with flawed RGS domains. We also investigated the correlation between RGS2 and STAT3 phosphorylation. RGS2 knock-down elevated Pam3 CSK4 induced STAT3 phosphorylation, but RGS2 overexpression had the opposite effect on STAT3 phosphorylation. These results suggest that, while Pam3 CSK4 induced TF expression is regulated by JAK2-STAT3 signaling, RGS2 is a negative regulator targeted to STAT3.
authors.affiliation: Department of Biochemistry and Molecular Biology, Aging-Associated Vascular Disease Research Center, College of Medicine, Yeungnam University, Daegu 705-802, Republic of Korea.
authors.forename: Dae-Weon
authors.initials: DW
authors.lastname: Park
authors.forename: Ji Hyo
authors.initials: JH
authors.lastname: Lyu
authors.forename: Jin-Sik
authors.initials: JS
authors.lastname: Kim
authors.forename: Haemin
authors.initials: H
authors.lastname: Chin
authors.forename: Yoe-Sik
authors.initials: YS
authors.lastname: Bae
authors.forename: Suk-Hwan
authors.initials: SH
authors.lastname: Baek
mesh_terms: D000818:Animals; D050197:Atherosclerosis; D002460:Cell Line; D053614:Janus Kinase 2 / Q000378:metabolism*; D055666:Lipopeptides / Q000494:pharmacology; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D020710:RGS Proteins / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction; D013925:Thromboplastin / Q000235:genetics / Q000378:metabolism*; D051195:Toll-Like Receptor 2 / Q000819:agonists / Q000378:metabolism*; D014158:Transcription, Genetic; D015533:Transcriptional Activation
chemical_list: D055666:Lipopeptides; C508075:Pam(3)CSK(4) peptide; D020710:RGS Proteins; C105345:Rgs2 protein, mouse; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; D013925:Thromboplastin; C507926:Jak2 protein, mouse; D053614:Janus Kinase 2